Journal of Advanced Prosthodontics

作者在投稿时必须披露是否使用了人工智能辅助技术（包括大语言模型、聊天机器人或图像生成工具），并在投稿信及稿件相应部分说明工具名称和用途：写作辅助须在致谢部分说明，数据分析、数据收集或图表生成须在材料与方法部分说明。 模型中文摘要

Authors must disclose at submission whether artificial intelligence–assisted technologies, including large language models, chatbots, or image-generation tools, were used in preparing the manuscript. The name of the tool and the purpose for which it was used must be described in the cover letter and in the appropriate section of the manuscript: use for writing assistance must be described in the A…

JAP将作者定义为对整项工作及自身贡献承担公开责任的人，所有作者须在以下四方面均做出实质性贡献：(1) 研究的设计构思、数据获取或数据分析与解释；(2) 撰写论文或对论文进行重要的学术内容修改；(3) 对待发表版本进行最终审定；(4) 同意对工作的所有方面负责。 模型中文摘要

JAP defines an “author” as a person whose participation in the work is sufficient for taking public responsibility for the work as a whole and the author’s own contributions. Specifically, all authors should have made substantial contributions to all of the following: (1) conception and design of the study, acquisition of the data, or analysis and interpretation of the data; and (2) drafting of th…

每位作者必须通过填写并提交作者表披露所有潜在利益冲突（COI）；COI指可能影响或被他人合理认为可能影响作者判断、行为或稿件的经济关系或其他情形，无论是否实际产生影响均须披露，JAP将决定披露内容的哪些部分随稿件发表。 模型中文摘要

Each author must disclose all potential conflicts of interest (COI) by completing and submitting the Author Form. A COI is a financial relationship or other circumstance that may affect, or may reasonably be thought by others to affect, an author’s judgment, conduct, or manuscript. A COI must be disclosed regardless of whether it has actually influenced, or is believed to influence, the author's j…

作者必须在稿件中提供数据可用性声明，说明支持研究结果的数据是否可用及在何处可用；若因伦理、隐私、法律或专有限制无法共享数据，声明须解释原因；临床试验的数据可用性声明还须符合ICMJE临床试验数据共享声明要求，包括是否共享个体去标识化参与者数据、共享哪些数据及共享条件。 模型中文摘要

Authors must provide a Data Availability statement in the manuscript describing whether, and where, the data supporting the reported findings are available. If the underlying data cannot be shared because of ethical, privacy, legal, or proprietary restrictions, the statement must explain the reason. For clinical trials, the Data Availability statement must also comply with the ICMJE requirements f…

论文被接受的前提是论文的任何实质性部分未曾或不会在其他地方发表，且接受后论文版权转让给韩国修复学会；未经许可不得复制论文；若与投稿稿件密切相关的论文已在其他地方发表或投稿，作者必须在投稿信中说明。 模型中文摘要

Papers are accepted on the understanding that no substantial part has been or will be published elsewhere, in whole or in part, and that upon acceptance, copyright of the article is transferred to The Korean Academy of Prosthodontics. If papers closely related to the submitted manuscript have been published or submitted for publication elsewhere, the author must state this in the cover letter. The…

JAP要求所有临床试验在ICMJE认可的公开注册机构进行前瞻性注册，采用WHO的临床试验定义，注册须在首例参与者签署知情同意时或之前完成，1期试验和器械可行性试验不豁免此要求。 模型中文摘要

JAP requires prospective registration of all clinical trials in a publicly accessible registry accepted by the ICMJE. JAP has adopted the WHO’s definition of a clinical trial: “any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.” Registration must be completed at or before the t…